Brenda Ta
ESA-SRB-NZSE-CaSR 2026 in conjunction with ENSA
Days
Saturday, 31st October
Sunday, 1st November
Monday, 2nd November
Tuesday, 3rd November
Wednesday, 4th November
Search
Speakers
Brenda Ta
Dr Brenda Ta is a final year endocrinology trainee at Westmead Hospital and PhD student at The University of Sydney. Her PhD focuses on safer transition strategies with denosumab.
Abstracts this author is presenting:
Balancing efficacy and rebound risk: extending denosumab dosing intervals in low-risk patients
—
Joint Poster Session